Prevalence of primary clarithromycin resistance in Helicobacter pylori strains over a 15 year period in Italy
about
Antibiotic treatment for Helicobacter pylori: Is the end coming?Helicobacter pylori Antibody Titer and Gastric Cancer ScreeningSecond and third line treatment options for Helicobacter pylori eradicationA review of Helicobacter pylori diagnosis, treatment, and methods to detect eradication.Rapid detection of clarithromycin resistant Helicobacter pylori strains in Spanish patients by polymerase chain reaction-restriction fragment length polymorphismPNA-FISH as a new diagnostic method for the determination of clarithromycin resistance of Helicobacter pylori.Standard triple, bismuth pectin quadruple and sequential therapies for Helicobacter pylori eradicationRandomized controlled trial comparing 7-day triple, 10-day sequential, and 7-day concomitant therapies for Helicobacter pylori infectionIn Vitro Activity of 2-methoxy-1,4-naphthoquinone and Stigmasta-7,22-diene-3β-ol from Impatiens balsamina L. against Multiple Antibiotic-Resistant Helicobacter pyloriHigh frequency of A2143G mutation in clarithromycin-resistant Helicobacter pylori isolates recovered from dyspeptic patients in Iran.Hybrid therapy for Helicobacter pylori infection: A systemic review and meta-analysis.A Randomized Controlled Study Comparing Reverse Hybrid Therapy and Standard Triple Therapy for Helicobacter pylori InfectionDetection of A2142C, A2142G, and A2143G Mutations in 23s rRNA Gene Conferring Resistance to Clarithromycin among Helicobacter pylori Isolates in Kerman, Iran.Validation of a fluorescence in situ hybridization method using peptide nucleic acid probes for detection of Helicobacter pylori clarithromycin resistance in gastric biopsy specimens.Primary clarithromycin resistance to Helicobacter pylori: Is this the main reason for triple therapy failure?Detection of Helicobacter pylori resistance to clarithromycin and fluoroquinolones in Brazil: A national surveyHow antibiotic resistances could change Helicobacter pylori treatment: A matter of geography?Preliminary examination of herbal extracts on the inhibition of Helicobacter pylori.Sequential vs. prolonged 14-day triple therapy for Helicobacter pylori eradication: the meta-analysis may be influenced by 'geographical weighting'.Prevalence of primary and secondary antimicrobial resistance of Helicobacter pylori in Korea from 2003 through 2012.Helicobacter pylori Eradication Therapies in the Era of Increasing Antibiotic Resistance: A Paradigm Shift to Improved Efficacy.A Randomized Controlled Trial Shows that both 14-Day Hybrid and Bismuth Quadruple Therapies Cure Most Patients with Helicobacter pylori Infection in Populations with Moderate Antibiotic Resistance.Antibiotic susceptibility of Helicobacter pylori in Iceland.New bismuth-containing quadruple therapy in patients infected with Helicobacter pylori: A first Italian experience in clinical practice.Helicobacter pylori DNA isolation in the stool: an essential pre-requisite for bacterial noninvasive molecular analysis.Reverse sequential therapy achieves a similar eradication rate as standard sequential therapy for Helicobacter pylori eradication: a randomized controlled trial.Geographic map and evolution of primary Helicobacter pylori resistance to antibacterial agents.Randomised controlled trial: sequential vs. standard triple therapy for Helicobacter pylori infection in Chinese children-a multicentre, open-labelled study.Evolution of Helicobacter pylori susceptibility to antibiotics during a 10-year period in Lithuania.High Helicobacter pylori resistance to metronidazole but zero or low resistance to clarithromycin, levofloxacin, and other antibiotics in Malaysia.Helicobacter pylori clarithromycin resistance detected by Etest and TaqMan real-time polymerase chain reaction: a comparative study.Berberine Combined with Triple Therapy versus Triple Therapy for Eradication: A Meta-Analysis of Randomized Controlled Trials
P2860
Q26777623-924C19FD-287C-4CAE-B429-9B80946C4A79Q26780322-A6AEBC56-9AA6-4514-890D-90D34FF7F11DQ26829666-66A079B4-536F-42B5-9B1E-C90CCC0CE0A4Q27687842-CCE65A14-5D82-42AA-9C9D-124174CA5147Q33766917-6DE65A8A-0212-4CED-903E-D54F488158D7Q33899160-4D01F343-414D-45A3-A211-96A880285BA0Q34117880-531813DB-D2CD-4F00-8C30-BC9313EEBEE8Q34299125-4AF8ED84-9677-4D68-B8F0-B46BB1F50531Q35108009-3481740F-F77E-4425-A13F-C5E94E2D9617Q35564328-882DCB69-385B-4AF0-9D2B-5545D0E503D0Q35868940-2293563A-8F98-41FF-9318-DB6DDD92EC41Q36359069-6D3085F7-50BE-4923-A429-8129CFB3AF92Q36567075-C0673167-47E3-4E6A-8270-11810D08D48CQ37026545-B42C5003-CE74-462D-AA6A-BBD408E85707Q37087009-4FA67C71-EA8D-4BD6-95E1-F023943F6331Q37232726-C430B834-25C3-4068-8D4F-DD10490D0D9BQ37378899-405EBFCE-B660-45F7-9082-2CB777F4D8CFQ37642674-073D2C4A-0722-43FE-BEC6-EAA4C98F503CQ38542168-667B3316-18C2-42E8-815E-ACB691402D08Q39503264-F5B162DC-0C4A-4058-AE48-6DABE2706992Q39588933-267C2D21-F925-4FE2-B5FB-4D77981882ADQ40093546-71B39F16-3FE3-49A1-83DC-471054A78571Q40238873-3B2C7111-7307-4DF8-9CC1-20A0B0917E99Q40357081-64DC34A7-941F-4C2D-BCCE-B3A5A3C46656Q40521935-3006B3C4-156C-4CC3-812D-491ADEF71755Q41606075-04DF844C-443B-4B78-875D-5DE90F5493F9Q43218781-DFFD5431-BA64-4FD3-A027-A74F64335CF2Q43854108-2437ECEB-3291-4E56-8390-9746F6F38790Q44106210-F78023B1-CD04-4C88-9196-950A12D02D6CQ51462455-3673BEB4-620E-497A-88E0-CD0218478B83Q54297418-4188E3A7-F56E-4A78-9A2C-844DDD1F0D70Q58583648-B37177CD-E345-4EAF-9C6C-FD6F188C2525
P2860
Prevalence of primary clarithromycin resistance in Helicobacter pylori strains over a 15 year period in Italy
description
article
@en
im Februar 2007 veröffentlichter wissenschaftlicher Artikel
@de
wetenschappelijk artikel
@nl
наукова стаття, опублікована в лютому 2007
@uk
name
Prevalence of primary clarithr ...... over a 15 year period in Italy
@en
Prevalence of primary clarithr ...... over a 15 year period in Italy
@nl
type
label
Prevalence of primary clarithr ...... over a 15 year period in Italy
@en
Prevalence of primary clarithr ...... over a 15 year period in Italy
@nl
prefLabel
Prevalence of primary clarithr ...... over a 15 year period in Italy
@en
Prevalence of primary clarithr ...... over a 15 year period in Italy
@nl
P2093
P2860
P50
P356
P1476
Prevalence of primary clarithr ...... over a 15 year period in Italy
@en
P2093
Antonella Pace
Carmine Panella
Floriana Giorgio
Giuseppe Stoppino
Marcella Margiotta
Mariangela Zotti
Osvaldo Burattini
Sergio Morini
Vincenzo De Francesco
P2860
P304
P356
10.1093/JAC/DKM005
P407
P577
2007-02-28T00:00:00Z